WuXi’s toxicology facility in Suzhou has received a statement of Good Laboratory Practice (GLP) from the Belgium Scientific Institute of Public Health on behalf of the Organization for Economic Cooperation and Development (OECD) after successfully passing three GLP inspections conducted by the Belgium GLP Monitorate. GLP is a quality system concerned with the organizational processes and conditions under which health safety studies are planned, performed, monitored, recorded, archived, and reported.
A five-day inspection of the facility was conducted by a team of inspectors from the Belgian national GLP compliance monitoring authority in February 2014. This facility also successfully passed two previous inspections by the OECD in 2010 and 2012, and also passed two inspections by the SFDA/CFDA.
The Belgian GLP statement for WuXi’s Suzhou toxicology facility further acknowledges the quality of our services, which meets the highest international standards.
See official press release Here.
WuXi Completes Construction of New Biosafety Testing Facility in Suzhou
WuXi’s Facilities for Late- and Commercial-Stage Analytical and Stability Testing and Clinical-Trial Materials Manufacturing Passes FDA Audit